Full_width_1920x800.jpg

Future proofing

with the Medisca

MAZ® mixer

With its unique patented capabilities, minimal to no maintenance, versatility without calibration, and 10+ years of research and development work, with established operating procedures and 175+ formulas – the MAZ planetary mixer is bridging the gaps in pharmaceutical compounding and consumer goods production.

Shop now

MAZ mixersAccessories

Key capabilities

Homogenisation
In a matter of seconds, homogenize creams, gels, ointments, liquids, and powders with uniform distribution of active ingredients. Evidence supporting this can be seen in HPLC assay results that tested the top, middle, and bottom layers of a cream containing baclofen, bupivacaine HCl, cyclobenzaprine, and diclofenac - and found relative standard deviations (RSD) of less than 3% and as low as 0% when mixed in the MAZ mixer1. Similar results were also seen when mixing T3 and T4 in a powder blend, resulting in an RSD value of less than 1.5%2.

Formula M 000 105

Continuous development

The Medisca MAZ mixer would not be what it is today without our commitment to continuous testing, research, development, and innovation. Today, the MAZ mixer is backed by 8+ patents, 175+ formulas, proprietary operating procedures, a team of 10+ MAZ specialists, and a dedicated MAZ lab located in Scottsdale, Arizona. By choosing the MAZ mixer, you will benefit from an ever-evolving technology and platform that continues to remain at the forefront of the industry.

MAZ formulas
MAZ LAB

Our programs

Explore our MAZ programs designed to support and enhance your experience. From warranty options that safeguard your investment, to a rewarding referral program that appreciates your recommendations, and a trade-in program that keeps your operations up-to-date with the latest technology.

Inspiring stories from

our customers

"The Medisca MAZ mixer has changed the way we blend, create, diversify and operate our business. We have reduced our R&D time and cost by over 60% using this innovative machine. Our customers know the difference and appreciate the technology."

Kelly Ann Lewis-Bortman

Founder & President, Covalent Custom Cannabinoids

Need help

getting started?

References:

  1. Medisca. (2016). Stability-indicating HPLC analysis of active ingredient concentration throughout the preparation.
  2. Medisca. (2023). Stability-indicating HPLC analysis of levothyroxine and liothyronine.
  3. Medisca (2017). Deaerating capability of the MAZ as assessed by measuring specific gravity.

  4. Medisca. (2016). Particle size testing with the ointment mill and Medisca® MAZ Mixer.
*For clarity, Medisca does not supply cannabis nor its derivatives. Medisca makes no representations regarding the legality of any uses of the MAZ mixer in connection with the processing of cannabis. In all cases it is the responsibility of the customer to be knowledgeable of the prohibitions and legal requirements attendant to the use of cannabis in their respective jurisdiction, and to abide by any such legal restrictions. The use of the MAZ mixer is at the sole risk and responsibility of the customer.